Renal disease in hepatitis C-positive liver transplant recipients

Transplantation

Volumn 63, Issue 9, 1997, Pages 1287-1293

  Kendrick, Elizabeth A ^a   McVicar, John P ^a   Kowdley, Kris V ^a   Bronner, Mary P ^a   Emond, Mary J ^a   Alpers, Charles E ^a   Gretch, David R ^a   Carithers Jr , Robert L ^a   Perkins, James D ^a   Davis, Connie L ^a,b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b Box 356174 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; AZATHIOPRINE; CREATININE; CRYOGLOBULIN; CYCLOSPORIN A; HLA DQ ANTIGEN; LYMPHOCYTE ANTIBODY; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HEPATITIS C VIRUS; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; RECIPIENT;

ADULT; BIOPSY; CREATININE; FEMALE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEPATITIS C; HLA-DQ ANTIGENS; HUMANS; HYPERTENSION; INTERFERON ALFA-2B; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES; SCLEROSIS;

EID: 17544392230     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00016     Document Type: Article

References (62)

1. Dische F, Neuberger J, Keating J, Parsons V, Calne R, Williams R. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A. Lab Invest 1988; 58(4): 395.
2. Eid A, Steffen R, Porayko M, et al. Beyond 1 year after liver transplantation. Mayo Clin Proc 1989; 64: 446.
3. Monsour HP Jr, Wood RP, Dyer CH, Galati JS, Ozaki CF, Clark JH. Renal insufficiency and hypertension as long-term complications in liver transplantation. Semin Liver Dis 1995; 15(2): 123.
4. Newell G. Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis 1987; 9: 183.
5. Crawford D, Endre Z, Axelsen R, et al. Universal occurrence of glomerular abnormalities in patients receiving liver transplants. Am J Kidney Dis 1992; 19(4): 339.
6. Eknoyan G. Glomerular abnormalities in liver disease. In: Epstein M, ed. The kidney in liver disease. Baltimore: Williams & Wilkins, 1988: 154.
7. Gilboa N, Hopp L, Agostini R. IgA nephritis in a patient with Alagille syndrome and a transplanted liver. Pediatr Nephrol 1992; 6(6): 559.
8. Johnson R, Gretch D, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465.
9. D'Amico G, Colasanti G, Ferrario F, Sinico R. Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989; 35: 1004.
10. Johnson R, Gretch D, Couser W, et al. Hepatitis C virus-associated glomerulonephritis: effect of alpha-interferon therapy. Kidney Int 1994; 46: 1700.
11. Misiani R, Bellavita P, Fenili D, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751.
12. Gretch D, Lee W, Corey L. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol 1992; 30: 2145.
13. Davidson F, Simmonds P, Ferguson J, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76: 1197.
14. Okamoto H, Sugiyama Y, Osada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673.
15. Enamoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990; 170: 1021.
16. Simmonds P, Alberti A, Alter H, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321.
17. Wikaen A. American Society of Histocompatibility and Immuno-genetics laboratory manual, 3rd ed. Lenexa, KS: ASHI, 1994.
18. Bugawan T, Erlich H. Rapid typing of HLA DQ B1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991; 33: 163.
19. Gretch D, Wile M, Gaur L, et al. Donor-recipient match at the HLA-DQB locus is associated with recrudescence of chronic hepatitis following liver transplantation for end stage hepatitis C [Abstract]. Hepatology 1993; 18 (4 Pt 2): 108A.
20. Desmet V, Gerber M, Hoofnagle J, Manns M, Scheuer P. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513.
21. Demetris A. Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases liver transplantation database nomenclature and grading system for cellular rejection of liver allografts. Hepatology 1995; 21: 408.
22. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73(1): 13.
23. Berg K, Forre O, Bjerkhoel F, et al. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int 1986; 29: 1180.
24. Myers B, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590.
25. Nizze H, Mihatsch M, Zollinger H, et al. Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants. Clin Nephrol 1988; 30(5): 248.
26. Palestine A, Austin H, Balow J, et al. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 1986; 314(20): 1293.
27. Young E, Ellis C, Messana J, et al. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney Int 1994; 46: 1216.
28. Gonwa T, Klintmalm G, Levy M, Jennings L, Goldstein R, Husberg B. Impact of pre-transplant renal function on survival after liver transplantation. Transplantation 1995; 59(3): 361.
29. Gonwa T, Morris C, Goldstein R, Husberg B, Klintmalm G. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome: experience in 300 patients. Transplantation 1991; 51(2): 428.
30. Wheatley H, Datzman M, Williams J, Miles D, Hatch F. Long-term effects of cyclosporine on renal function in liver transplant recipients. Transplantation 1987; 43(5): 641.
31. Hossein-Nia M, Devlin J, Fagbohun M, et al. Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506. Transplant Proc 1991; 23(6): 3150.
32. McCauley J, Fung J, Todo S, Jain A, Deballi P, Starzl T. Changes in renal function after liver transplantation under FK506. Transplant Proc 1991; 23(6): 3143.
33. Randhawa P, Shapiro R, Jordan M, Starzl T, Demetris A. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Am J Surg Pathol 1993; 17(1): 60.
34. Nochy C, Callard P, Bellon B, et al. Hepatic glomerulonephritis and liver disease: a study of 34 patients. Clin Nephrol 1976; 6: 422.
35. Nakamoto Y, Hiroyuki I, Kobayashi K, et al. Hepatic glomerulonephritis. Virchows Arch A Pathol Anat 1981; 392: 45.
36. Berger J, Yaneva H, Nabarra B. Glomerular changes in patients with cirrhosis of the liver. Adv Nephrol 1978; 7: 7.
37. Milner L, Houser M, Kolbeck P, et al. Glomerular injury in end-stage liver disease: role of circulating IgG and IgM immune complexes. Pediatr Nephrol 1993; 7(1): 6.
38. Noble-Jamison G, Thiru S, Johnston P, Friend P, Barnes N. Glomerulonephritis with end-stage liver disease in childhood. Lancet 1992; 339: 706.
39. Davis C, Gretch D, Perkins J, et al. Hepatitis C-associated glomerular disease in liver transplant recipients. Liver Transplant Surg 1995; 1(3): 166.
40. Ghabra N, Piraino B, Greenberg A, Banner B. Resolution of cirrhotic glomerulonephritis following successful liver transplantation. Clin Nephrol 1991; 35(1): 6.
41. Mansfield C, Bhan I, Kurtin P. IgA nephropathy as a possible cause of renal insufficiency following liver transplantation. Child Nephrol Urol 1991; 11(4): 220.
42. Stehman-Breen C, Alpers C, Couser W, Willson R, Johnson R. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 1995; 43: 141.
43. Yamabe H, Johnson R, Gretch D, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6(2): 220.
44. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573.
45. Davada R, Peterson J, Weiner R, Croker B, Lau J. Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 1993; 22: 452.
46. D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995; 25(3): 361.
47. Burstein D, Rodby R. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol 1993; 4: 1288.
48. Gournay J, Ferrell L, Roberts J, Ascher N, Wright T, Lake J. Cryoglobulinemia presenting after liver transplantation. Gastroenterology 1996; 110(1): 265.
49. Hoofnagle J, DiBisceglie A. Treatment of chronic type C hepatitis with alpha interferon. Semin Liver Dis 1989; 9(4): 259.
50. Saracco G, Rizzetto M. The long-term efficacy of interferon alfa in chronic hepatitis C patients: a critical review. J Gastroenterol Hepatol 1995; 10(6): 668.
51. Wright T, Combs C, Kim M, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20(4): 773.
52. Feray C, Samuel D, Gigou M, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995; 22: 1084.
53. Ferrell L, Wright T, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16: 865.
54. Gane E, Portmann B, Naoumov N, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334(13): 815.
55. Gretch D, Bacchi C, Corey L, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995; 22(1): 1.
56. Hino K, Sainokami S, Shimoda K, et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299.
57. Ascher N, Lake J, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994; 20(1) Pt. 2, suppl: 24S.
58. Wright T, Donegan E, Hsu H, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317.
59. Ferri C, Marzo E, Longombardo G, et al. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993; 81: 1132.
60. Gane E, Naoumov N, Qian K, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167.
61. Allison M, Wreghitt T, Palmer C, Alexander G. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21(6): 1135.
62. Gray H, Wreghitt T, Stratton I, Alexander G, Turner R, O'Rahilly S. High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 1995; 12(3): 244.